Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deepak Parashar

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
NPJ Precision Oncology|June 5, 2024
Blocking Oncostatin M receptor abrogates STAT3 mediated integrin signaling and overcomes chemoresistance in ovarian cancerAnjali Geethadevi, Zhiqiang Ku, Shirng-Wern Tsaih, et al.
Asian Journal of Andrology|March 1, 2016
Transperineal prostate biopsies for diagnosis of prostate cancer are well tolerated: a prospective study using patient-reported outcome measuresKaran Wadhwa, Lina Carmona-Echeveria, Timur Kuru, et al.
Cancer Immunology, Immunotherapy : CII|October 1, 2016
Predicting PD-L1 expression on human cancer cells using next-generation sequencing information in computational simulation modelsEmily A Lanzel, M Paula Gomez Hernandez, Amber M Bates, et al.
Cell Death & Disease|November 21, 2025
Activated protein C promotes human lung cancer progression through the release of tumor extracellular vesicles and transfer of microRNA-200aMadhura Chatterjee, Deepak Parashar, Rajan Pandey, et al.
Cancers|February 25, 2022
Patient-Derived Ovarian Cancer Spheroids Rely on PI3K-AKT Signaling Addiction for Cancer Stemness and ChemoresistanceDeepak Parashar, Anjali Geethadevi, Sonam Mittal, et al.
Cancers|May 28, 2022
Correction: Parashar et al. Patient-Derived Ovarian Cancer Spheroids Rely on PI3K-AKT Signaling Addiction for Cancer Stemness and Chemoresistance. <i>Cancers</i> 2022, <i>14</i>, 958Deepak Parashar, Anjali Geethadevi, Sonam Mittal, et al.
Cancer Research|October 22, 2020
Peritoneal Spread of Ovarian Cancer Harbors Therapeutic Vulnerabilities Regulated by FOXM1 and EGFR/ERBB2 SignalingDeepak Parashar, Bindu Nair, Anjali Geethadevi, et al.
Pediatric Blood & Cancer|August 15, 2015
The UK Experience of a Treatment Strategy for Pediatric Metastatic Medulloblastoma Comprising Intensive Induction Chemotherapy, Hyperfractionated Accelerated Radiotherapy and Response Directed High Dose Myeloablative Chemotherapy or Maintenance Chemotherapy (Milan Strategy)Sindu Vivekanandan, Richard Breene, Ramya Ramanujachar, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 15, 2022
Tumor Derived Extracellular Vesicles Drive T Cell Exhaustion in Tumor Microenvironment through Sphingosine Mediated Signaling and Impacting Immunotherapy Outcomes in Ovarian CancerPrachi Gupta, Ishaque Pulikkal Kadamberi, Sonam Mittal, et al.
Cancer Research|August 12, 2021
Oncostatin M Receptor-Targeted Antibodies Suppress STAT3 Signaling and Inhibit Ovarian Cancer GrowthAnjali Geethadevi, Ajay Nair, Deepak Parashar, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
NPJ Precision Oncology|June 5, 2024
Blocking Oncostatin M receptor abrogates STAT3 mediated integrin signaling and overcomes chemoresistance in ovarian cancerAnjali Geethadevi, Zhiqiang Ku, Shirng-Wern Tsaih, et al.
Asian Journal of Andrology|March 1, 2016
Transperineal prostate biopsies for diagnosis of prostate cancer are well tolerated: a prospective study using patient-reported outcome measuresKaran Wadhwa, Lina Carmona-Echeveria, Timur Kuru, et al.
Cancer Immunology, Immunotherapy : CII|October 1, 2016
Predicting PD-L1 expression on human cancer cells using next-generation sequencing information in computational simulation modelsEmily A Lanzel, M Paula Gomez Hernandez, Amber M Bates, et al.
Cell Death & Disease|November 21, 2025
Activated protein C promotes human lung cancer progression through the release of tumor extracellular vesicles and transfer of microRNA-200aMadhura Chatterjee, Deepak Parashar, Rajan Pandey, et al.
Cancers|February 25, 2022
Patient-Derived Ovarian Cancer Spheroids Rely on PI3K-AKT Signaling Addiction for Cancer Stemness and ChemoresistanceDeepak Parashar, Anjali Geethadevi, Sonam Mittal, et al.
Cancers|May 28, 2022
Correction: Parashar et al. Patient-Derived Ovarian Cancer Spheroids Rely on PI3K-AKT Signaling Addiction for Cancer Stemness and Chemoresistance. <i>Cancers</i> 2022, <i>14</i>, 958Deepak Parashar, Anjali Geethadevi, Sonam Mittal, et al.
Cancer Research|October 22, 2020
Peritoneal Spread of Ovarian Cancer Harbors Therapeutic Vulnerabilities Regulated by FOXM1 and EGFR/ERBB2 SignalingDeepak Parashar, Bindu Nair, Anjali Geethadevi, et al.
Pediatric Blood & Cancer|August 15, 2015
The UK Experience of a Treatment Strategy for Pediatric Metastatic Medulloblastoma Comprising Intensive Induction Chemotherapy, Hyperfractionated Accelerated Radiotherapy and Response Directed High Dose Myeloablative Chemotherapy or Maintenance Chemotherapy (Milan Strategy)Sindu Vivekanandan, Richard Breene, Ramya Ramanujachar, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 15, 2022
Tumor Derived Extracellular Vesicles Drive T Cell Exhaustion in Tumor Microenvironment through Sphingosine Mediated Signaling and Impacting Immunotherapy Outcomes in Ovarian CancerPrachi Gupta, Ishaque Pulikkal Kadamberi, Sonam Mittal, et al.
Cancer Research|August 12, 2021
Oncostatin M Receptor-Targeted Antibodies Suppress STAT3 Signaling and Inhibit Ovarian Cancer GrowthAnjali Geethadevi, Ajay Nair, Deepak Parashar, et al.
Pageof 10